See more : Daiki Aluminium Industry Co., Ltd. (5702.T) Income Statement Analysis – Financial Results
Complete financial analysis of Waters Corporation (WAT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Waters Corporation, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- China Science Publishing & Media Ltd. (601858.SS) Income Statement Analysis – Financial Results
- SoldOut, Inc. (6553.T) Income Statement Analysis – Financial Results
- Stingray Group Inc. (RAY-A.TO) Income Statement Analysis – Financial Results
- Sharda Motor Industries Limited (SHARDAMOTR.NS) Income Statement Analysis – Financial Results
- Environmental Clean Technologies Limited (ECT.AX) Income Statement Analysis – Financial Results
Waters Corporation (WAT)
About Waters Corporation
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.96B | 2.97B | 2.79B | 2.37B | 2.41B | 2.42B | 2.31B | 2.17B | 2.04B | 1.99B | 1.90B | 1.84B | 1.85B | 1.64B | 1.50B | 1.58B | 1.47B | 1.28B | 1.16B | 1.10B | 958.21M | 889.97M | 859.21M | 795.07M | 704.40M | 618.80M | 465.50M | 391.10M | 333.00M |
Cost of Revenue | 1.20B | 1.25B | 1.16B | 1.01B | 1.01B | 992.56M | 947.07M | 891.45M | 842.67M | 824.91M | 783.46M | 737.61M | 730.49M | 653.30M | 594.88M | 661.27M | 631.12M | 536.19M | 478.36M | 454.81M | 397.85M | 373.47M | 311.23M | 265.90M | 235.60M | 213.40M | 158.70M | 133.60M | 109.70M |
Gross Profit | 1.76B | 1.72B | 1.63B | 1.36B | 1.40B | 1.43B | 1.36B | 1.28B | 1.20B | 1.16B | 1.12B | 1.11B | 1.12B | 990.07M | 903.82M | 913.86M | 841.93M | 744.04M | 679.88M | 649.73M | 560.36M | 516.50M | 547.98M | 529.17M | 468.80M | 405.40M | 306.80M | 257.50M | 223.30M |
Gross Profit Ratio | 59.57% | 58.00% | 58.49% | 57.44% | 58.00% | 58.98% | 58.99% | 58.87% | 58.74% | 58.53% | 58.86% | 59.99% | 60.54% | 60.25% | 60.31% | 58.02% | 57.16% | 58.12% | 58.70% | 58.82% | 58.48% | 58.04% | 63.78% | 66.56% | 66.55% | 65.51% | 65.91% | 65.84% | 67.06% |
Research & Development | 174.95M | 176.19M | 168.36M | 140.78M | 142.96M | 143.40M | 132.59M | 125.19M | 118.55M | 107.73M | 100.54M | 96.00M | 92.35M | 84.27M | 77.15M | 81.59M | 80.65M | 77.31M | 66.91M | 65.24M | 59.24M | 51.92M | 46.60M | 42.51M | 36.10M | 34.40M | 80.80M | 20.90M | 17.70M |
General & Administrative | 690.34M | 651.03M | 619.97M | 547.70M | 528.79M | 529.90M | 538.70M | 502.03M | 484.75M | 500.71M | 481.97M | 464.27M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 7.00M | 7.00M | 7.00M | 6.00M | 6.00M | 7.00M | 6.00M | 11.00M | 11.00M | 12.00M | 11.00M | 13.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 736.01M | 658.03M | 626.97M | 553.70M | 534.79M | 536.90M | 544.70M | 513.03M | 495.75M | 512.71M | 492.97M | 477.27M | 490.01M | 445.46M | 421.40M | 426.70M | 403.70M | 357.66M | 321.69M | 300.15M | 264.25M | 246.82M | 269.71M | 246.39M | 226.60M | 206.20M | 167.30M | 148.50M | 132.70M |
Other Expenses | 32.56M | 6.37M | 7.14M | 10.59M | 9.69M | -47.79M | 6.74M | 9.89M | 10.12M | 10.63M | -1.58M | 13.83M | 9.73M | 10.41M | 10.66M | 15.82M | 8.70M | 5.44M | 8.13M | -466.00K | 16.77M | 13.95M | 82.14M | 29.44M | 29.60M | 28.40M | 21.10M | 17.80M | 16.50M |
Operating Expenses | 943.52M | 840.58M | 802.47M | 705.06M | 687.44M | 688.02M | 684.04M | 648.11M | 624.42M | 631.07M | 603.42M | 587.10M | 592.09M | 540.14M | 509.22M | 524.10M | 493.05M | 440.41M | 396.73M | 364.93M | 340.27M | 312.68M | 398.45M | 318.34M | 292.30M | 269.00M | 269.20M | 187.20M | 166.90M |
Cost & Expenses | 2.14B | 2.09B | 1.96B | 1.71B | 1.70B | 1.68B | 1.63B | 1.54B | 1.47B | 1.46B | 1.39B | 1.32B | 1.32B | 1.19B | 1.10B | 1.19B | 1.12B | 976.59M | 875.08M | 819.73M | 738.12M | 686.15M | 709.68M | 584.24M | 527.90M | 482.40M | 427.90M | 320.80M | 276.60M |
Interest Income | 16.62M | 11.02M | 12.22M | 16.27M | 22.06M | 38.81M | 36.08M | 20.69M | 10.71M | 7.02M | 4.39M | 4.21M | 2.62M | 1.86M | 3.04M | 0.00 | 0.00 | 0.00 | 19.26M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 98.86M | 37.78M | 32.72M | 32.80M | 26.63M | 9.83M | 20.76M | 24.23M | 25.53M | 27.17M | 25.66M | 23.87M | 19.35M | 12.07M | 7.95M | 17.56M | 25.69M | 32.19M | 8.59M | 0.00 | 0.00 | 5.51M | 2.10M | 10.64M | 9.00M | 34.90M | 30.10M | 39.20M | 39.20M |
Depreciation & Amortization | 165.91M | 130.42M | 131.68M | 125.36M | 105.30M | 108.41M | 106.00M | 96.45M | 10.12M | 10.63M | 9.92M | 13.83M | 9.73M | 10.41M | 10.66M | 65.27M | 53.32M | 46.16M | 43.69M | 41.93M | 33.85M | 37.19M | 33.95M | 29.44M | 29.60M | 28.40M | 21.10M | 17.80M | 16.50M |
EBITDA | 1.00B | 1.01B | 958.43M | 777.97M | 822.09M | 799.64M | 783.97M | 725.01M | 668.23M | 638.31M | 597.04M | 584.53M | 597.61M | 514.35M | 454.91M | 475.98M | 402.20M | 360.78M | 326.84M | 337.67M | 253.94M | 241.01M | 183.48M | 240.26M | 206.10M | 164.80M | 58.70M | 88.10M | 72.90M |
EBITDA Ratio | 33.86% | 34.18% | 35.03% | 33.28% | 33.66% | 33.06% | 33.95% | 29.42% | 28.66% | 27.35% | 27.61% | 28.90% | 29.08% | 28.01% | 27.04% | 29.30% | 27.30% | 28.44% | 28.76% | 29.19% | 27.93% | 29.75% | 30.91% | 30.22% | 29.26% | 29.30% | 16.15% | 28.79% | 24.53% |
Operating Income | 817.68M | 873.40M | 821.71M | 645.49M | 708.46M | 739.77M | 661.86M | 624.34M | 567.45M | 517.91M | 517.34M | 511.49M | 528.60M | 449.93M | 394.60M | 389.75M | 348.88M | 295.15M | 283.16M | 284.86M | 219.17M | 196.41M | 149.53M | 210.83M | 176.50M | 136.40M | 37.60M | 70.30M | 56.40M |
Operating Income Ratio | 27.66% | 29.39% | 29.50% | 27.29% | 29.44% | 30.57% | 28.66% | 28.81% | 27.78% | 26.03% | 27.17% | 27.74% | 28.55% | 27.38% | 26.33% | 24.74% | 23.68% | 23.05% | 24.45% | 25.79% | 22.87% | 22.07% | 17.40% | 26.52% | 25.06% | 22.04% | 8.08% | 17.97% | 16.94% |
Total Other Income/Expenses | -81.43M | -35.55M | -15.51M | -34.58M | -30.22M | -57.63M | -21.10M | -24.93M | -25.53M | -27.17M | -27.24M | -23.87M | -19.35M | -12.07M | -7.95M | -17.56M | -25.69M | -36.78M | -8.59M | 813.00K | 4.51M | -1.00M | -2.10M | 135.00K | -9.00M | -34.90M | -30.10M | -39.20M | -39.20M |
Income Before Tax | 736.24M | 837.85M | 806.19M | 610.91M | 678.24M | 682.15M | 641.10M | 600.11M | 541.92M | 490.74M | 490.11M | 487.63M | 509.25M | 437.86M | 386.65M | 372.19M | 323.19M | 262.96M | 274.56M | 285.67M | 223.69M | 195.41M | 147.43M | 210.96M | 167.50M | 101.50M | 7.50M | 31.10M | 17.20M |
Income Before Tax Ratio | 24.90% | 28.19% | 28.94% | 25.83% | 28.18% | 28.19% | 27.76% | 27.69% | 26.53% | 24.67% | 25.74% | 26.45% | 27.51% | 26.64% | 25.80% | 23.63% | 21.94% | 20.54% | 23.71% | 25.86% | 23.34% | 21.96% | 17.16% | 26.53% | 23.78% | 16.40% | 1.61% | 7.95% | 5.17% |
Income Tax Expense | 94.01M | 130.09M | 113.35M | 89.34M | 86.04M | 88.35M | 620.79M | 78.61M | 72.87M | 59.12M | 40.10M | 26.18M | 76.28M | 56.10M | 63.34M | 49.71M | 55.12M | 40.76M | 72.59M | 61.62M | 52.80M | 43.19M | 32.88M | 54.85M | 45.20M | 27.10M | 15.80M | 11.20M | 3.10M |
Net Income | 642.23M | 707.76M | 692.84M | 521.57M | 592.20M | 593.79M | 20.31M | 521.50M | 469.05M | 431.62M | 450.00M | 461.44M | 432.97M | 381.76M | 323.31M | 322.48M | 268.07M | 222.20M | 201.98M | 224.05M | 170.89M | 147.71M | 114.54M | 145.34M | 122.30M | 74.40M | -8.30M | -2.40M | 2.00M |
Net Income Ratio | 21.72% | 23.81% | 24.87% | 22.05% | 24.61% | 24.54% | 0.88% | 24.06% | 22.97% | 21.70% | 23.63% | 25.03% | 23.39% | 23.23% | 21.57% | 20.47% | 18.20% | 17.36% | 17.44% | 20.28% | 17.83% | 16.60% | 13.33% | 18.28% | 17.36% | 12.02% | -1.78% | -0.61% | 0.60% |
EPS | 10.87 | 11.80 | 11.25 | 8.40 | 8.76 | 7.71 | 0.25 | 6.46 | 5.70 | 5.12 | 5.27 | 5.25 | 4.77 | 4.13 | 3.37 | 3.25 | 2.67 | 2.16 | 1.77 | 1.87 | 1.39 | 1.13 | 0.88 | 1.14 | 0.99 | 0.61 | -0.07 | -0.02 | 0.01 |
EPS Diluted | 10.84 | 11.73 | 11.17 | 8.36 | 8.69 | 7.65 | 0.25 | 6.41 | 5.65 | 5.07 | 5.20 | 5.19 | 4.69 | 4.06 | 3.34 | 3.21 | 2.62 | 2.13 | 1.74 | 1.82 | 1.34 | 1.09 | 0.83 | 1.06 | 0.92 | 0.57 | -0.07 | -0.02 | 0.01 |
Weighted Avg Shares Out | 59.08M | 59.99M | 61.58M | 62.09M | 67.63M | 76.99M | 79.79M | 80.79M | 82.34M | 84.36M | 85.43M | 87.84M | 90.83M | 92.39M | 95.80M | 99.20M | 100.50M | 102.69M | 114.02M | 119.64M | 123.19M | 130.49M | 130.56M | 127.57M | 123.01M | 119.72M | 116.51M | 120.00M | 110.00M |
Weighted Avg Shares Out (Dil) | 59.27M | 60.33M | 62.03M | 62.41M | 68.17M | 77.62M | 80.60M | 81.42M | 83.09M | 85.15M | 86.55M | 88.98M | 92.33M | 94.06M | 96.86M | 100.56M | 102.51M | 104.24M | 115.95M | 123.07M | 127.58M | 135.76M | 137.51M | 136.74M | 132.63M | 119.72M | 116.51M | 120.00M | 110.00M |
Artificial Intelligence Risk Inc. Named as Waters Technology's "Best buy-side AI platform or tool (compliance)" for the AIR- GPT Gen AI Platform
Waters Stock Leads S&P 500 Gains Friday as Earnings Top Estimates
S&P 500 Gains and Losses Today: Waters Stock Surges as Sales Improve
Waters Corporation (WAT) Q3 2024 Earnings Call Transcript
Waters (WAT) Beats Q3 Earnings and Revenue Estimates
Waters Corp raises annual profit forecast on higher demand for lab equipment
Waters Corporation (NYSE: WAT) Reports Third Quarter 2024 Financial Results
Sailing In International Waters With LVHI
Waters (WAT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Why Waters (WAT) is Poised to Beat Earnings Estimates Again
Source: https://incomestatements.info
Category: Stock Reports
How did Waters Corporation’s EPS change in 2023?
On a GAAP basis, EPS for fiscal year 2023 was $10.84, compared to $11.73 for fiscal year 2022. On a non-GAAP basis, EPS was $11.75, compared to $12.02 in fiscal year 2022. This includes a headwind of approximately 3% due to unfavorable foreign exchange and a 1% dilution from the Wyatt acquisition.
What were Waters Corporation’s revenue and profits in 2023?
For fiscal year 2023, the Company’s sales were $2,956 million, a decrease of 0.5% as reported, compared to sales of $2,972 million for fiscal year 2022. Currency translation decreased sales by approximately 1%, while the impact of acquisitions increased sales by 2.5%.
How did the Wyatt acquisition affect Waters’ 2023 financials?
In 2023, we completed the largest acquisition in Waters history with Wyatt Technology LLC, which contributed 2.5% to our revenues.